Galectin-1 knockdown increases sensitivity to temozolomide in a B16F10 mouse metastatic melanoma model. [electronic resource]
Producer: 20071002Description: 2399-410 p. digitalISSN:- 1523-1747
- Animals
- Antineoplastic Agents -- therapeutic use
- Antineoplastic Agents, Alkylating -- pharmacology
- Apoptosis -- drug effects
- Cathepsin B -- metabolism
- Cell Line, Tumor
- Cisplatin -- therapeutic use
- Dacarbazine -- analogs & derivatives
- Disease Models, Animal
- Female
- Galectin 1 -- genetics
- Gene Expression Regulation, Neoplastic -- drug effects
- HSP72 Heat-Shock Proteins -- physiology
- Melanoma -- drug therapy
- Mice
- Mice, Knockout
- RNA, Small Interfering -- pharmacology
- Skin Neoplasms -- drug therapy
- Temozolomide
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.